Blue Cross Blue Shield of Michigan Drops Wegovy and Others Blue Cross Blue Shield of Michigan (BCBS MI), the states largest nonprofit insurer covering over 4.5 million members, recently announced it will stop covering three major GLP-1 medications Wegovy , Zepbound , and Saxenda for fully insured large groups, effective January 2025
Preclinical experiments across different species, using various models and conducted by independent laboratories, show that central or peripheral administration of GLP-1RAs reduce alcohol intake and other related outcomes such as alcohol-induced conditioned place preference [197, 204, 205]
Fortunately, a denial does not mean you are out of options
This can happen if you start eating more once the appetite control fades or when losing muscle slows down your metabolism
Doctors look at GLP-1 to help people with type 2 diabetes and people who are overweight
In dual or multi-responsive systems, actions occur potentially at the same site concurrently or in sequential order in multiple compartments